FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30225711000001102: Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93967501000001119 Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93967601000001115 Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has VMP Atazanavir 300mg / Cobicistat 150mg tablets true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has specific active ingredient Cobicistat false Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has specific active ingredient Atazanavir sulfate true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Atazanavir true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has specific active ingredient Cobicistat true Inferred relationship Existential restriction modifier
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Has basis of strength substance Atazanavir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet Is a True Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start